NCT01933932 · Interventional trial
Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC
Overall registry status Active not recruiting
Phase 3
Conditions Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory